The above studies have shown that HAT and HDAC inhibitors can increase the level of histone acetylation, enhance the expression of memory-related genes, prevent cognitive degeneration and Aβ protein deposition, affect abnormal tau phosphorylation, and reduce NFT formation, thus delaying the progression of AD, while deacetylase has the opposite effect. This evidence concerns the gene MAPT and Alzheimer disease.